Neuronetics, Inc. is a commercial stage medical technology company, which focuses on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders. The company is headquartered in Malvern, Pennsylvania and currently employs 716 full-time employees. The company went IPO on 2018-06-28. The Company’s NeuroStar Advanced Therapy (NeuroStar Therapy) is a non-drug, noninvasive treatment that can improve the quality of life for people suffering from neurohealth conditions. In addition to selling the NeuroStar Advanced Therapy System (NeuroStar System) and associated treatment sessions to customers, it operates Greenbrook treatment centers across the United States, offering NeuroStar Therapy for the treatment of major depressive disorder (MDD) and other mental health disorders. Spravato is offered to treat adults with treatment-resistant depression and depressive symptoms in adults with MDD with suicidal thoughts or actions. MDD is a recurrent disease and follows a fluctuating course over an individual’s lifetime. The firm provides more than 7.1 million treatments to over 1,95,000 patients.
Follow-Up Questions
Neuronetics Inc 'in CEO'su kimdir?
Mr. Keith Sullivan 2020 'den beri şirketle birlikte olan Neuronetics Inc 'in President 'ıdır.
STIM hissesinin fiyat performansı nasıl?
STIM 'in mevcut fiyatı $2.96 'dir, son işlem günde 1.75% increased etti.
Neuronetics Inc için ana iş temaları veya sektörler nelerdir?
Neuronetics Inc Health Care endüstrisine ait ve sektör Health Care 'dir
Neuronetics Inc 'in piyasa değerlemesi nedir?
Neuronetics Inc 'in mevcut piyasa değerlemesi $195.7M 'dir
Neuronetics Inc al, sat, yoksa beklemeli mi?
Wall Street analistlerine göre, 5 analist Neuronetics Inc için analist derecelendirmeleri gerçekleştirdi, bunlar 2 güçlü al, 6 al, 1 tut, 0 sat ve 2 güçlü sat içermektedir
